Article Details

Scopus BioPharma Retaining Counsel to Investigate Unusual - GlobeNewswire

Retrieved on: 2021-10-01 20:26:15

Tags for this article:

Click the tags to see associated articles and topics

Scopus BioPharma Retaining Counsel to Investigate Unusual - GlobeNewswire. View article details on hiswai:

Excerpt

NEW YORK, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company, announced today that it is ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up